Efficacy of ICI Combined with Chemotherapy in Patients with Advanced Penile Squamous Cell Carcinoma By Ogkologos - October 1, 2025 5 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the HERCULES (LACOG 0218) study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extending Indications for Pembrolizumab and Adopted a New Pharmaceutical Form Along with a New Route of Administration FDA Approves Pembrolizumab and Berahyaluronidase alfa-pmph for Subcutaneous Injection Study presents an AI-guided approach to target cancer antigens MOST POPULAR EMA Recommends Granting a Marketing Authorisation for Fedratinib December 23, 2020 How Joining a Clinical Trial Helped Me Find Hope While Living... December 5, 2023 New on NCI’s Websites for March 2019 March 29, 2019 Speaking with One Cancer Voice for cancer patients in England March 29, 2023 Load more HOT NEWS EMA Recommends Refusal of the Marketing Authorisation for Pexidartinib NICE doesn’t recommend ibrutinib drug for those with Waldenstrom’s macroglobulinaemia India’s First Homegrown CAR T-Cell Therapy Has Roots in NCI Collaboration FDA Approves First Immunotherapy Treatment For Breast Cancer
